Discover
TEVA
Teva Pharmaceutical Industries Limited
33.44
200 x undefined
200 x undefined
bid
ask
-
0.44
1.30%
200 @ 07:18 AM
33.67 +0.23 (0.70%)
| Ytd | 7.15% | |
| 1y | 100.96% |
33.26
day range
34.08
14.99
52 week range
37.35
| Open | 33.83 | Prev Close | 33.88 | Low | 33.26 | High | 34.08 | Mkt Cap | 38.94B |
| Vol | 4.24M | Avg Vol | 6.21M | EPS | 1.34 | P/E | 24.96 | Forward P/E | 11.00 |
| Beta | 0.85 | Short Ratio | 5.60 | Inst. Own | 62.34% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 11-27 | Earning | 07-29 | 50-d Avg | 33.93 | 200-d Avg | 29.32 | 1yr Est | 40.90 |
| Income Statement | |||
| Total Revenue | 3.98B | ||
| Revenues (USD) | 3.98B | ||
| Cost of Revenue | 2.01B | ||
| Gross Profit | 1.97B | ||
| Operating Expenses | 1.33B | ||
| Research and Development Expense | 222.00M | ||
| Selling, General and Administrative Expense | 1000.00M | ||
| Operating Income | 643.00M | ||
| Interest Expense | 216.00M | ||
| Income Tax Expense | 67.00M | ||
| Net Income | 369.00M | ||
| Net Income Common Stock | 369.00M | ||
| Net Income Common Stock (USD) | 369.00M | ||
| Consolidated Income | 369.00M | ||
| Earnings per Basic Share | 0.32 | ||
| Earnings per Basic Share (USD) | 0.32 | ||
| Earnings per Diluted Share | 0.31 | ||
| Earning Before Interest & Taxes (EBIT) | 652.00M | ||
| Earning Before Interest & Taxes (USD) | 652.00M | ||
| Weighted Average Shares | 1.16B | ||
| Weighted Average Shares Diluted | 1.18B | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.74B | ||
| Cash and Equivalents (USD) | 3.74B | ||
| Trade and Non-Trade Receivables | 3.39B | ||
| Current Assets | 13.71B | ||
| Property, Plant & Equipment Net | 4.33B | ||
| Total Assets | 40.04B | ||
| Debt Current | 2.61B | ||
| Total Debt | 16.91B | ||
| Current Liabilities | 13.53B | ||
| Debt Non-Current | 14.30B | ||
| Total Liabilities | 31.81B | ||
| Accumulated Retained Earnings (Deficit) | -13.39B | ||
| Accumulated Other Comprehensive Income | -2.51B | ||
| Shareholders Equity | 8.23B | ||
| Shareholders Equity (USD) | 8.23B | ||
| Assets Non-Current | 26.33B | ||
| Total Debt (USD) | 16.91B | ||
| Goodwill and Intangible Assets | 19.43B | ||
| Inventory | 3.18B | ||
| Liabilities Non-Current | 18.28B | ||
| Trade and Non-Trade Payables | 2.60B | ||
| Tax Assets | 2.19B | ||
| Tax Liabilities | 3.98B | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 239.00M | ||
| Net Cash Flow from Financing | 13.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 185.00M | ||
| Capital Expenditure | -168.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 42.00M | ||
| Issuance (Repayment) of Debt Securities | -23.00M | ||
| Net Cash Flow from Investing | 229.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 354.00M | ||
| Net Cash Flow from Operations | -40.00M | ||
| Effect of Exchange Rate Changes on Cash | -17.00M | ||
| Share Based Compensation | 43.00M | ||